Daniel P. DeCollibus

Daniel DeColllibus earned is B.S in biochemistry from the University of Tampa and M.S. in Bioscience Administration from Worcester Polytechnic Institute. He has over 14 years experience in drug product formulation and process development and is currently employed at Amgen as a Sr. Scientist in the Commercial Process Development organization. During his time in industry, he has worked on various drug modalities, including biologics, peptides, and oligonucleotide therapeutics. He is also a co-leader of the European Pharma Oligonucleotide Consortium (EPOC) working group on terminal sterilisation.